Cell and gene therapy are forms of medical treatment that have been at the forefront of research in the last few decades. A growing field of research, cell-based therapies involve modification of a patient’s own cells or cells from a donor to fight diseases or alleviate medical conditions to help patients continue to live their … Continued
Current and Future Approaches to Immunotherapy
The History of Cell and Gene Therapy
Immunotherapies Used to Treat Cancer
Frequently Asked Questions About Cell and Gene Therapies
The Technology Behind Bone Marrow Cellular Processing: The PXP® System
Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing
For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.
Products for Cellular Processing and Storage
We offer closed automated solutions for manual steps in the cell manufacturing process. Our flexible automated modules provide performance gains in purifying mononuclear cells, washing contaminants from cell fractions, cell selection, and storage while significantly shortening processing times.
3D Bag Set
Cryopreservation is the process of using ultra-low temperatures to preserve living cells for long periods of time. It is an essential aspect of the cell manufacturing process of many cell therapies. While there are multiple factors to consider for developing a cryopreservation process that will ensure safe and effective manufacturing of cell therapies, below are … Continued
As more and more cell and gene therapies are being developed, there is an emerging need for the industrialization of cell manufacturing. With greater production also comes more regulation, and the industry is in need of processes that are scalable and still meet the requirements of Good Manufacturing Practices (GMP) for cell manufacturing. Cell … Continued
Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., May 13, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2021 … Continued
Mindy Wilke-Douglas, currently the Vice President of Operations, has been with ThermoGenesis since 2008. During a company-wide restructuring, she went back to the academic field, but eagerly accepted the opportunity to return when it became available. That’s how much she believes in the mission of the company and in the passion and work ethic that … Continued
Conference Call to be Held on May 13, 2021 RANCHO CORDOVA, Calif., May 6, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2021 … Continued